deltaDOT analytical technology is based on an innovative approach to Capillary Electrophoresis (CE). Patented multipoint sensor system together with the proprietary computing algorithms give superior resolution, accuracy and repeatability. This is High Performance Capillary Electrophoresis (HPCE) at its best - Label Free Intrinsic Imaging (LFII™), this technology has found successful applications in detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and bacteria, drugs, chemicals and a wide range of other analytes.

deltaDOT Label Free technology allows the direct monitoring of unlabelled biomolecules offering faster and higher quality results at a fraction of the cost of conventional approaches.

deltaDOT received new investment in May 2010 as a part of the Company's financial and management restructuring. The Company is poised for a significant drive in the market exploitation of their unique technology. In addition to previous sales and applications of the Peregrine machines, a number of major international players and government organizations have successfully evaluated deltaDOT LFII™ technology for their specific applications.

deltaDOT HPCE applies molecular biology and particle physics technology to the needs of biomolecular separation, including protein, DNA and RNA analysis.

The company has a strong proprietary position and extensive expertise in instrumentation, molecular biology, microfluidics, automation, computing and analysis which will contribute to improvements in knowledge, profitability and process time throughout drug discovery and general life sciences research.